Far Eastern Medical Foundation Far Eastern Memorial Hospital
New Taipei City, 220, Taiwan
NCT Number: NCT07230561
The goal of this clinical trial is to learn if a structured early exercise program can help patients recover better in people who have just had coronary artery bypass surgery. The main questions it aims to answer are:
* Does this early exercise improve fitness and walking ability? * Does it reduce the risk of muscle weakness (sarcopenia) after surgery? * Does it improve patients' quality of life? * Does it reduce feelings of anxiety and depression? Researchers will compare the group receiving the structured early exercise program (plus standard hospital care) to the group receiving standard hospital care only to see if the early exercise program leads to better and faster recovery.
Participants in the exercise group will:
* Start supervised exercise sessions within 24 hours after their surgery. * Perform these sessions twice a day for 30 minutes each, for 5 days. * The exercises include warm-ups, breathing exercises, walking or stationary cycling, and light resistance training.
Looking for future studies?
Notify Me40 year–85 year
All sexes
Interventional
Not applicable
New Taipei City, 220, Taiwan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The training protocol was developed by integrating Phase 1 cardiac rehabilitation guidelines with an expert consensus approach from a multidisciplinary team. The intervention began within 24 hours postoperatively, was conducted for 5 days, twice daily, 30 min/session. Sessions included a 5-min warm-up (active/passive ROM), a 20-min main training (FITT principle: Intensity at resting heart rate + 20 bpm, max 120 bpm; Type: inspiratory muscle training, ROM, stationary cycling or bedside ambulation, resistance training), and a 5-min cool-down.
The standard hospital nursing care included physiological monitoring, medication counseling, psychological support, disease-specific health education, instruction on the use of an incentive spirometer, and education on the importance and methods of rehabilitation.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed by the 6-minute walk test (6MWT). Total distance (in meters) walked along a 30-meter flat corridor in six minutes.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed using the Strength, Assistance with walking, Rising from a chair, Climbing stairs, and Falls (SARC-F) questionnaire. The total score ranges from 0 to 10. Higher scores indicate a greater risk of sarcopenia (worse outcome). Classified as "at risk" (SARC-F total score more than or equal to 4 points) or "not at risk".
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed using the Strength, Assistance with walking, Rising from a chair, Climbing stairs, and Falls (SARC-F) questionnaire. The total score ranges from 0 to 10. Higher scores indicate a greater risk of sarcopenia (worse outcome).
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed by maximal handgrip strength (in kg) using a hydraulic dynamometer.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed by maximal handgrip strength (in kg) using a hydraulic dynamometer.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Time (in seconds) taken to stand and sit five times from a chair with arms crossed.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Maximum circumference (in cm) at the widest part of the calf while seated.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Maximum circumference (in cm) at the widest part of the calf while seated.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed using the EuroQol 5-Dimension 3-Level (EQ-5D-3L) questionnaire. The index score typically ranges from 0 to 1.00. Higher scores indicate a better quality of life (better outcome), with 1.00 representing perfect health and 0 representing death.
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed using the EuroQol visual analogue scale (EQ-VAS). Scale 0 (worst imaginable) to 100 (best imaginable).
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed using the Hospital Anxiety and Depression Scale (HADS) Anxiety subscale. Score ranges from 0 to 21. Higher scores indicate higher levels of anxiety (worse outcome).
Time frame: Baseline (preoperative at admission), Postoperative Day 6, Postoperative Day 14
Assessed using the Hospital Anxiety and Depression Scale (HADS) Depression subscale. Score ranges from 0 to 21. Higher scores indicate higher levels of depression (worse outcome).
Ta-Chung Chao
Other
The Efficacy of Structured Early Mobilization Training in Patients After Coronary Artery Bypass Surgery: A Randomized Controlled Trial
Acronym: EMAC
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05726019
Acute Coronary Syndrome, Arterial Occlusive Diseases
São Paulo, Brazil
View Trial DetailsNCT00489827
Angina Pectoris, Angina, Unstable
Karlskrona, Sweden
View Trial DetailsNCT05497687
Arterial Occlusive Diseases, Arteriosclerosis
Hong Kong
View Trial DetailsNCT04560309
Arterial Occlusive Diseases, Arteriosclerosis
Jakarta, Indonesia
View Trial Details